Aurobindo Pharma’s stock shows resistance at Rs 1177, with a promising technical outlook. Traders are advised to consider a Bull Call Spread strategy proposed by Mehta for potential upside movements.
India’s retail investment boom is driven by tech and gamification but raises risks. Regulatory reforms on transparency, investor education, and gamification practices are essential to
Indian companies are experiencing a decline in shareholder dissent, with resolutions facing over 20% opposition from institutional investors dropping to 16% this fiscal year. Increased
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003